Paperonium

Diabetes · Diabetes Care · 2021

Only 2 deaths, yet a margin of error nearly 4× too narrow makes transplants look protective.

The paper’s marginbelow all three groupsCorrect for 2 deathscovers all threeEarlier group: 5.31Pittsburgh study, a subgroupEarlier group: 7.99a separate county registryEarlier group: 10.79Pittsburgh study, whole group2.12 to 5.050.40 to 11.840 deaths per 1,000 patients a year1015no deaths
The paper’s marginbelow allthree groupsCorrectfor 2 deathscovers all threeEarlier group: 5.31Pittsburgh study,a subgroupEarlier group: 7.99a separatecounty registryEarlier group: 10.79Pittsburgh study,whole group5.052.1211.840.40051015no deathsdeathsper 1,000 patientsa year

Deaths per 1,000 patients a year; bars span rates the data can’t rule out

The paper says

Of 49 type 1 diabetes patients given insulin-making cell transplants, 2 died. The paper gives 3.28 deaths per 1,000 patients a year (margin of error 2.12 to 5.05), lower than in three earlier groups of type 1 patients, and suggests transplants may protect against death.

Its own data show

The rate matches its own counts: 2 deaths in 610.1 years of follow-up, all patients combined. But 2 deaths leave lots of room for luck: the standard calculation for small counts gives 0.40 to 11.84, nearly 4 times as wide, covering all three earlier rates (5.31 to 10.79). The paper’s margin fits about 20 deaths.

A margin of error is the span of death rates the data can’t rule out, and the fewer the deaths, the wider it is. If these patients truly died at the lowest of the three earlier rates, 5.31, 2 or fewer deaths would still happen more than 1 time in 3. So the data can’t show transplants protect against death.

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

Survival After Islet Transplantation in Subjects With Type 1 Diabetes: Twenty-Year Follow-Up · Diabetes Care (2021) · doi:10.2337/dc20-2458